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INTRODUCTION 
Renal transplant is now the accepted mode of treatment of end stage renal disease (ESRD)1. The major
causes of ESRD being diabetes mellitus, hypertension, glomerulonephritis, polycystic kidney disease
and other/unknown2. The most common glomerular disease in renal allograft biopsies is transplant
glomerulopathy3, i.e., those lesions related to transplant rejections. Other glomerulonephropathies (GN)
also occur which are recurrences of GN the original disease which caused ESRD, diseases related to
the donor and those without any explanation called denovo GN. One hundred five well documented
cases of denovo occurrence of membranous GN in renal allograft have been reported in medical
literature. We present a case from Pakistan where approximately 1,000 transplanted patients are being
followed-up.
CASE REPORT 
A 48 year old male was diagnosed as having ESRD secondary to hypertension. He received a renal
allograft from a living non- related donor. For immunosuppression he was on azathioprine 100 mg,
prednisolone 10 mg and cycloporin 160 mg daily and hypertension was controlled by atenolol 100 mg
and prazocin 8 mg daily. He remained well for three year post transplant when he noticed bilateral
oedema of feet which gradually increased. There were no symptoms relating to his urinary tract and his
urinary output remained unchanged. On examination, he had bilateral pitting pedal oedema extending
upto mid calf but did not have fever, pallor, jaundice orlymphadenopathy. His jugular venous pressure
was not raised and blood pressure was 140/80 mmHg. His cardiovascular, respiratory, CNS and
abdominal examinations were normal. His right lower quadrant graft area was non-tender and without a
bruit. The investigations revealed proteinuria of > 4gm/24 hours with a normal microscopy, serum
albumin of 1.8 gm/dl and fasting cholesterol of 320 mg/dl. His creatinine rose to 2.1 mg/dl from his
baseline post-transplant level of 1.6 mg/dl. The electrolyte, cyclosporin levels, ESR, autoimmune
profile and hepatitis B profile did not reveal any abnormality.A lower pole renal transplant biopsy was
done under ultrasound guidance and the specimen was subjected to light microscopy,
immunofluorescence and electron microscopy. On light microscopy it showed swelling of glomerular
epithelial cells and thickening of basement membrane, on silver stains the basement membrane was
thick and demonstrated “spike” formation. There was no evidence of acute or chronic rejection or
cyclosporine toxicity. Immunofluoresceure revealed anti-JgG 3+ granular staining along capillary walls
and anti-C3 patchy 1+ granular staining along capillary walls. Electron midroscopy (Figure 1 and 2)

revealed irregularly thickened basement membrane with dense deposit distributed along the
subepithelial aspects; these were separated and occasionally surrounded by basement membrane
extensions. Epithelial foot processes demonstrated effacement and the tubules showed mild
degenerative change (Figure 3).
DISCUSSION 
Apart from transplant glomerulonephropathies recurrence of glomerulonephritis in a renal allograft
occur in 6-9% of cases4 and these have different morphological forms like diffuse proliferative,
crescentric, membranous and focal sclerosis5-7. The most common gI omerular lesion which occurs
denovo is membranous GN (MGN) the reported incidence in the West being 2-9%3. MGN may occur
between four months to six years following transplant with a mean Of 21 months8. The diagnosis is
suspected when nephrotic syndrome is not associated with obvious clinical features of rejection, while
renal function is either normal or slightly decreased. It is confirmed by excluding recurrence of GN and
by the histological picture. The denovo MGN progress to renal failure more rapidly than the idiopathic
form3 and the graft survival is poor9. There is no relationship with the type of graft, age, sex, race and
antigen matching. To the best of our knowledge this is the first case of denovo membranous
glomerulonephropathy in a renal allograft reported from Pakistan.
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